Toolkit/self-assembled proteomimetic

self-assembled proteomimetic

Multi-Component Switch·Research·Since 2025

Also known as: SAP

Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

Self-assembled proteomimetic (SAP) is a multi-component binding scaffold built from short PNA-peptide conjugates that assemble into a proteomimetic three-helix-bundle-like architecture. In the cited study, SAPs were generated against HER2 and the SARS-CoV-2 spike receptor-binding domain, and an RBD-targeting SAP inhibited viral entry with an IC50 of 2.8 nM.

Usefulness & Problems

Why this is useful

SAP provides an antibody-like binding modality from short, self-assembling PNA-peptide components rather than a conventional folded protein scaffold. The reported system is useful because its affinity can be chemically regulated through toehold-mediated displacement of the hybridizing PNA elements, enabling externally controlled binding.

Source:

An RBD-targeting SAP effectively inhibits SARS-CoV-2 viral entry with an IC50 of 2.8 nM.

Problem solved

SAP addresses the problem of creating high-affinity, target-specific binders from compact synthetic components that can be assembled and regulated post-assembly. The cited work specifically demonstrates target engagement for HER2 and SARS-CoV-2 RBD and shows chemical control over binding through disruption of the assembly-stabilizing PNA interaction.

Source:

An RBD-targeting SAP effectively inhibits SARS-CoV-2 viral entry with an IC50 of 2.8 nM.

Published Workflows

Objective: Create synthetically accessible antibody-like binders by assembling self-assembled proteomimetics from short PNA-peptide conjugates and discover target-specific binders through combinatorial preparation and affinity selection.

Why it works: The workflow couples T-NCL, which dramatically accelerates ligation at low micromolar concentrations, with one-operation preparation of small SAP libraries that can be directly subjected to affinity selection and LC-MS identification of the fittest binders.

hybridization-enforced two-helix coiled-coil formationtemplated native chemical ligation of PNA-peptide conjugatestoehold displacement-mediated disruption of coiled-coil stabilizationtemplated native chemical ligationcombinatorial library preparationaffinity selectionLC-MS analysis

Stages

  1. 1.
    Combinatorial SAP library preparation(library_build)

    This stage creates small combinatorial SAP libraries that can be used directly in downstream affinity selections.

    Selection: Preparation of small combinatorial libraries of SAPs in one operation

  2. 2.
    Affinity selection against target of interest(selection)

    This stage enriches the library for binders to the target of interest before analytical identification.

    Selection: Binding to a target of interest

  3. 3.
    LC-MS analysis of fittest binders(secondary_characterization)

    This stage identifies the fittest binders after selection.

    Selection: Analysis of the fittest binders recovered from affinity selection

Steps

  1. 1.
    Assemble SAPs from PNA-peptide conjugates by templated native chemical ligationengineered binder platform and enabling assembly chemistry

    Generate SAP constructs in a combinatorial fashion from short synthetic components.

    Assembly must occur first to create the SAP library that will be subjected to affinity selection.

  2. 2.
    Use the SAP library directly in affinity selections against a target of interestscreened binder library

    Enrich for SAP binders that best recognize the target of interest.

    Selection follows library preparation because only assembled SAP variants can be tested for target binding.

  3. 3.
    Analyze the fittest binders by LC-MSanalytical readout method

    Identify the fittest binders recovered from affinity selection.

    LC-MS analysis is performed after selection because it reads out the enriched binder set rather than the starting library.

Taxonomy & Function

Primary hierarchy

Mechanism Branch

Architecture: A composed arrangement of multiple parts that instantiates one or more mechanisms.

Target processes

selection

Input: Chemical

Implementation Constraints

SAPs are described as assemblies of short PNA-peptide conjugates in which hybridizing PNA segments enforce stabilization of two-helix coiled coils to mimic a three-helix bundle. The reported control mechanism uses toehold-mediated strand displacement to disrupt the hybridizing PNAs and thereby modulate affinity; no additional expression, cofactor, or delivery details are provided in the supplied evidence.

The supplied evidence is limited to a single 2025 source and two explicit claims, so breadth of validation across targets, cell types, and in vivo settings is not established here. Practical performance details such as stability, delivery, immunogenicity, reversibility kinetics, and manufacturing robustness are not provided in the supplied evidence.

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1allosteric regulationsupports2025Source 1needs review

SAP affinity can be allosterically regulated by toehold displacement of the hybridizing PNAs, which disrupts coiled-coil stabilization.

Claim 2allosteric regulationsupports2025Source 1needs review

SAP affinity can be allosterically regulated by toehold displacement of the hybridizing PNAs, which disrupts coiled-coil stabilization.

Claim 3allosteric regulationsupports2025Source 1needs review

SAP affinity can be allosterically regulated by toehold displacement of the hybridizing PNAs, which disrupts coiled-coil stabilization.

Claim 4allosteric regulationsupports2025Source 1needs review

SAP affinity can be allosterically regulated by toehold displacement of the hybridizing PNAs, which disrupts coiled-coil stabilization.

Claim 5allosteric regulationsupports2025Source 1needs review

SAP affinity can be allosterically regulated by toehold displacement of the hybridizing PNAs, which disrupts coiled-coil stabilization.

Claim 6allosteric regulationsupports2025Source 1needs review

SAP affinity can be allosterically regulated by toehold displacement of the hybridizing PNAs, which disrupts coiled-coil stabilization.

Claim 7allosteric regulationsupports2025Source 1needs review

SAP affinity can be allosterically regulated by toehold displacement of the hybridizing PNAs, which disrupts coiled-coil stabilization.

Claim 8allosteric regulationsupports2025Source 1needs review

SAP affinity can be allosterically regulated by toehold displacement of the hybridizing PNAs, which disrupts coiled-coil stabilization.

Claim 9application performancesupports2025Source 1needs review

An RBD-targeting SAP effectively inhibits SARS-CoV-2 viral entry with an IC50 of 2.8 nM.

IC50 2.8 nM
Claim 10application performancesupports2025Source 1needs review

An RBD-targeting SAP effectively inhibits SARS-CoV-2 viral entry with an IC50 of 2.8 nM.

IC50 2.8 nM
Claim 11application performancesupports2025Source 1needs review

An RBD-targeting SAP effectively inhibits SARS-CoV-2 viral entry with an IC50 of 2.8 nM.

IC50 2.8 nM
Claim 12application performancesupports2025Source 1needs review

An RBD-targeting SAP effectively inhibits SARS-CoV-2 viral entry with an IC50 of 2.8 nM.

IC50 2.8 nM
Claim 13application performancesupports2025Source 1needs review

An RBD-targeting SAP effectively inhibits SARS-CoV-2 viral entry with an IC50 of 2.8 nM.

IC50 2.8 nM
Claim 14application performancesupports2025Source 1needs review

An RBD-targeting SAP effectively inhibits SARS-CoV-2 viral entry with an IC50 of 2.8 nM.

IC50 2.8 nM
Claim 15application performancesupports2025Source 1needs review

An RBD-targeting SAP effectively inhibits SARS-CoV-2 viral entry with an IC50 of 2.8 nM.

IC50 2.8 nM
Claim 16application performancesupports2025Source 1needs review

An RBD-targeting SAP effectively inhibits SARS-CoV-2 viral entry with an IC50 of 2.8 nM.

IC50 2.8 nM
Claim 17binding performancesupports2025Source 1needs review

The SAP design paradigm is functional for structurally distinct three-helix peptides aimed at HER2 and spike RBD, reaching picomolar affinities.

binding affinity picomolar affinities
Claim 18binding performancesupports2025Source 1needs review

The SAP design paradigm is functional for structurally distinct three-helix peptides aimed at HER2 and spike RBD, reaching picomolar affinities.

binding affinity picomolar affinities
Claim 19binding performancesupports2025Source 1needs review

The SAP design paradigm is functional for structurally distinct three-helix peptides aimed at HER2 and spike RBD, reaching picomolar affinities.

binding affinity picomolar affinities
Claim 20binding performancesupports2025Source 1needs review

The SAP design paradigm is functional for structurally distinct three-helix peptides aimed at HER2 and spike RBD, reaching picomolar affinities.

binding affinity picomolar affinities
Claim 21binding performancesupports2025Source 1needs review

The SAP design paradigm is functional for structurally distinct three-helix peptides aimed at HER2 and spike RBD, reaching picomolar affinities.

binding affinity picomolar affinities
Claim 22binding performancesupports2025Source 1needs review

The SAP design paradigm is functional for structurally distinct three-helix peptides aimed at HER2 and spike RBD, reaching picomolar affinities.

binding affinity picomolar affinities
Claim 23binding performancesupports2025Source 1needs review

The SAP design paradigm is functional for structurally distinct three-helix peptides aimed at HER2 and spike RBD, reaching picomolar affinities.

binding affinity picomolar affinities
Claim 24binding performancesupports2025Source 1needs review

The SAP design paradigm is functional for structurally distinct three-helix peptides aimed at HER2 and spike RBD, reaching picomolar affinities.

binding affinity picomolar affinities
Claim 25method performancesupports2025Source 1needs review

T-NCL dramatically accelerates ligation and enables combinatorial chemistry at low micromolar concentrations.

concentration regime low micromolar concentrations
Claim 26method performancesupports2025Source 1needs review

T-NCL dramatically accelerates ligation and enables combinatorial chemistry at low micromolar concentrations.

concentration regime low micromolar concentrations
Claim 27method performancesupports2025Source 1needs review

T-NCL dramatically accelerates ligation and enables combinatorial chemistry at low micromolar concentrations.

concentration regime low micromolar concentrations
Claim 28method performancesupports2025Source 1needs review

T-NCL dramatically accelerates ligation and enables combinatorial chemistry at low micromolar concentrations.

concentration regime low micromolar concentrations
Claim 29method performancesupports2025Source 1needs review

T-NCL dramatically accelerates ligation and enables combinatorial chemistry at low micromolar concentrations.

concentration regime low micromolar concentrations
Claim 30method performancesupports2025Source 1needs review

T-NCL dramatically accelerates ligation and enables combinatorial chemistry at low micromolar concentrations.

concentration regime low micromolar concentrations
Claim 31method performancesupports2025Source 1needs review

T-NCL dramatically accelerates ligation and enables combinatorial chemistry at low micromolar concentrations.

concentration regime low micromolar concentrations
Claim 32method performancesupports2025Source 1needs review

T-NCL dramatically accelerates ligation and enables combinatorial chemistry at low micromolar concentrations.

concentration regime low micromolar concentrations
Claim 33strategy descriptionsupports2025Source 1needs review

SAP is a strategy to mimic three-helix bundle architecture using a hybridization-enforced two-helix coiled coil obtained by templated native chemical ligation of PNA-peptide conjugates.

Claim 34strategy descriptionsupports2025Source 1needs review

SAP is a strategy to mimic three-helix bundle architecture using a hybridization-enforced two-helix coiled coil obtained by templated native chemical ligation of PNA-peptide conjugates.

Claim 35strategy descriptionsupports2025Source 1needs review

SAP is a strategy to mimic three-helix bundle architecture using a hybridization-enforced two-helix coiled coil obtained by templated native chemical ligation of PNA-peptide conjugates.

Claim 36strategy descriptionsupports2025Source 1needs review

SAP is a strategy to mimic three-helix bundle architecture using a hybridization-enforced two-helix coiled coil obtained by templated native chemical ligation of PNA-peptide conjugates.

Claim 37strategy descriptionsupports2025Source 1needs review

SAP is a strategy to mimic three-helix bundle architecture using a hybridization-enforced two-helix coiled coil obtained by templated native chemical ligation of PNA-peptide conjugates.

Claim 38strategy descriptionsupports2025Source 1needs review

SAP is a strategy to mimic three-helix bundle architecture using a hybridization-enforced two-helix coiled coil obtained by templated native chemical ligation of PNA-peptide conjugates.

Claim 39strategy descriptionsupports2025Source 1needs review

SAP is a strategy to mimic three-helix bundle architecture using a hybridization-enforced two-helix coiled coil obtained by templated native chemical ligation of PNA-peptide conjugates.

Claim 40strategy descriptionsupports2025Source 1needs review

SAP is a strategy to mimic three-helix bundle architecture using a hybridization-enforced two-helix coiled coil obtained by templated native chemical ligation of PNA-peptide conjugates.

Claim 41synthetic accessibilitysupports2025Source 1needs review

The SAP strategy reduces the length of the longest synthetic peptide to less than 30 amino acids, making it readily attainable by standard SPPS methodologies.

longest synthetic peptide length 30 amino acids
Claim 42synthetic accessibilitysupports2025Source 1needs review

The SAP strategy reduces the length of the longest synthetic peptide to less than 30 amino acids, making it readily attainable by standard SPPS methodologies.

longest synthetic peptide length 30 amino acids
Claim 43synthetic accessibilitysupports2025Source 1needs review

The SAP strategy reduces the length of the longest synthetic peptide to less than 30 amino acids, making it readily attainable by standard SPPS methodologies.

longest synthetic peptide length 30 amino acids
Claim 44synthetic accessibilitysupports2025Source 1needs review

The SAP strategy reduces the length of the longest synthetic peptide to less than 30 amino acids, making it readily attainable by standard SPPS methodologies.

longest synthetic peptide length 30 amino acids
Claim 45synthetic accessibilitysupports2025Source 1needs review

The SAP strategy reduces the length of the longest synthetic peptide to less than 30 amino acids, making it readily attainable by standard SPPS methodologies.

longest synthetic peptide length 30 amino acids
Claim 46synthetic accessibilitysupports2025Source 1needs review

The SAP strategy reduces the length of the longest synthetic peptide to less than 30 amino acids, making it readily attainable by standard SPPS methodologies.

longest synthetic peptide length 30 amino acids
Claim 47synthetic accessibilitysupports2025Source 1needs review

The SAP strategy reduces the length of the longest synthetic peptide to less than 30 amino acids, making it readily attainable by standard SPPS methodologies.

longest synthetic peptide length 30 amino acids
Claim 48synthetic accessibilitysupports2025Source 1needs review

The SAP strategy reduces the length of the longest synthetic peptide to less than 30 amino acids, making it readily attainable by standard SPPS methodologies.

longest synthetic peptide length 30 amino acids
Claim 49workflow capabilitysupports2025Source 1needs review

Small combinatorial libraries of SAPs can be prepared in one operation and used directly in affinity selections with LC-MS analysis of the fittest binders.

Claim 50workflow capabilitysupports2025Source 1needs review

Small combinatorial libraries of SAPs can be prepared in one operation and used directly in affinity selections with LC-MS analysis of the fittest binders.

Claim 51workflow capabilitysupports2025Source 1needs review

Small combinatorial libraries of SAPs can be prepared in one operation and used directly in affinity selections with LC-MS analysis of the fittest binders.

Claim 52workflow capabilitysupports2025Source 1needs review

Small combinatorial libraries of SAPs can be prepared in one operation and used directly in affinity selections with LC-MS analysis of the fittest binders.

Claim 53workflow capabilitysupports2025Source 1needs review

Small combinatorial libraries of SAPs can be prepared in one operation and used directly in affinity selections with LC-MS analysis of the fittest binders.

Claim 54workflow capabilitysupports2025Source 1needs review

Small combinatorial libraries of SAPs can be prepared in one operation and used directly in affinity selections with LC-MS analysis of the fittest binders.

Claim 55workflow capabilitysupports2025Source 1needs review

Small combinatorial libraries of SAPs can be prepared in one operation and used directly in affinity selections with LC-MS analysis of the fittest binders.

Claim 56workflow capabilitysupports2025Source 1needs review

Small combinatorial libraries of SAPs can be prepared in one operation and used directly in affinity selections with LC-MS analysis of the fittest binders.

Approval Evidence

1 source6 linked approval claimsfirst-pass slug self-assembled-proteomimetic
Herein, we report a strategy, coined self-assembled proteomimetic (SAP), to mimic such three-helix bundle architecture with a hybridization-enforced two-helix coiled coil that is obtained by templated native chemical ligation (T-NCL) of PNA-peptide conjugates.

Source:

allosteric regulationsupports

SAP affinity can be allosterically regulated by toehold displacement of the hybridizing PNAs, which disrupts coiled-coil stabilization.

Source:

application performancesupports

An RBD-targeting SAP effectively inhibits SARS-CoV-2 viral entry with an IC50 of 2.8 nM.

Source:

binding performancesupports

The SAP design paradigm is functional for structurally distinct three-helix peptides aimed at HER2 and spike RBD, reaching picomolar affinities.

Source:

strategy descriptionsupports

SAP is a strategy to mimic three-helix bundle architecture using a hybridization-enforced two-helix coiled coil obtained by templated native chemical ligation of PNA-peptide conjugates.

Source:

synthetic accessibilitysupports

The SAP strategy reduces the length of the longest synthetic peptide to less than 30 amino acids, making it readily attainable by standard SPPS methodologies.

Source:

workflow capabilitysupports

Small combinatorial libraries of SAPs can be prepared in one operation and used directly in affinity selections with LC-MS analysis of the fittest binders.

Source:

Comparisons

Source-backed strengths

The cited study reports picomolar binding affinity for SAP binders and demonstrates functional antiviral activity for an RBD-targeting SAP with an IC50 of 2.8 nM in a viral entry assay. A further strength is that SAP affinity is allosterically regulated by toehold displacement of the hybridizing PNAs, linking target binding to a programmable nucleic-acid-like control input.

Ranked Citations

  1. 1.

    Extracted from this source document.